Dorn-Rasmussen Maria, Lo Bobby, Zhao Mirabella, Kaplan Gilaad G, Malham Mikkel, Wewer Vibeke, Burisch Johan
Department of Paediatric and Adolescence Medicine, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark.
Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark.
J Crohns Colitis. 2023 Mar 18;17(2):259-268. doi: 10.1093/ecco-jcc/jjac138.
Incidence rates of inflammatory bowel disease [IBD] reported from developed countries are rising, with some levelling out. The aim of this study was to assess the disease burden of IBD by estimating the incidence and prevalence across age groups and projecting these to 2030 in a high-incidence country.
Using an algorithm [incorporating ICD codes, medications and histopathology], patients [n = 69 862] diagnosed with Crohn's disease [CD] or ulcerative colitis [UC] between 1980 and 2017 were identified in the Danish National Patient Registry and included in a nationwide cohort.
From 1980 to 2017 the overall incidence of CD increased from 5.1 [95% CI: 4.5-5.8] to 15.6 [95% CI: 14.6-16.6] per 100 000, while the incidence of UC increased from 6.2 [95% CI: 5.5-6.9] to 27.2 [95% CI: 25.9-28.6] per 100 000. For paediatric-onset CD [pCD], the incidence increased from 1.9 [95% CI: 1.2-2.8] to 9.9 [95% CI: 8.1-11.8] per 100 000 and from 1.8 [95% CI: 1.2-2.8] to 8.7 [95% CI: 7.1- 10.5] per 100 000 for paediatric-onset UC [pUC]. In 2017, the prevalence of CD and UC was 293 [95% CI: 288-297] and 523 [95% CI: 517-528] per 100 000. For pCD and pUC, the prevalence was 35 [95% CI: 31-38] and 28 [95% CI: 26-32] per 100 000.
The incidence of paediatric- and adult-onset IBD in Denmark continues to increase and is among the highest in the world.
发达国家报告的炎症性肠病(IBD)发病率呈上升趋势,部分地区趋于平稳。本研究旨在通过估计各年龄组的发病率和患病率,并预测到2030年在一个高发病率国家的疾病负担。
使用一种算法(结合国际疾病分类代码、药物和组织病理学),在丹麦国家患者登记处识别出1980年至2017年间被诊断为克罗恩病(CD)或溃疡性结肠炎(UC)的患者(n = 69862),并将其纳入全国队列。
1980年至2017年,CD的总体发病率从每10万人5.1(95%可信区间:4.5 - 5.8)增至15.6(95%可信区间:14.6 - 16.6),而UC的发病率从每10万人6.2(95%可信区间:5.5 - 6.9)增至27.2(95%可信区间:25.9 - 28.6)。对于儿童期发病的CD(pCD),发病率从每10万人1.9(95%可信区间:1.2 - 2.8)增至9.9(95%可信区间:8.1 - 11.8),儿童期发病的UC(pUC)从每10万人1.8(95%可信区间:1.2 - 2.8)增至8.7(95%可信区间:7.1 - 10.5)。2017年,CD和UC的患病率分别为每10万人293(95%可信区间:288 - 297)和523(95%可信区间:517 - 528)。对于pCD和pUC,患病率分别为每10万人35(95%可信区间:31 - 38)和28(95%可信区间:26 - 32)。
丹麦儿童期和成人期发病的IBD发病率持续上升,位居世界最高水平之列。